<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39188722</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Obesity-compromised immunity in post-COVID-19 condition: a critical control point of chronicity.</ArticleTitle><Pagination><StartPage>1433531</StartPage><MedlinePgn>1433531</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1433531</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2024.1433531</ELocationID><Abstract><AbstractText>Post-COVID-19 condition is recognized as a multifactorial disorder, with persistent presence of viral antigens, discordant immunity, delayed viral clearance, and chronic inflammation. Obesity has emerged as an independent risk factor for both SARS-CoV-2 infection and its subsequent sequelae. In this study, we aimed to predict the molecular mechanisms linking obesity and post-COVID-19 distress. Viral antigen-exposed adipose tissues display remarkable levels of viral receptors, facilitating viral entry, deposition, and chronic release of inflammatory mediators and cells in patients. Subsequently, obesity-associated inflammatory insults are predicted to disturb cellular and humoral immunity by triggering abnormal cell differentiation and lymphocyte exhaustion. In particular, the decline in SARS-CoV-2 antibody titers and T-cell exhaustion due to chronic inflammation may account for delayed virus clearance and persistent activation of inflammatory responses. Taken together, obesity-associated defective immunity is a critical control point of intervention against post-COVID-19 progression, particularly in subjects with chronic metabolic distress.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Jang, Hong and Moon.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jang</LastName><ForeName>Soonwoo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Mucosal Exposome and Biomodulation, Department of Integrative Biomedical Sciences, Pusan National University, Yangsan, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Pusan National University, Yangsan, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research Institute, Pusan National University Hospital, Yangsan, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Wooyoung</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moon</LastName><ForeName>Yuseok</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Laboratory of Mucosal Exposome and Biomodulation, Department of Integrative Biomedical Sciences, Pusan National University, Yangsan, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Pusan National University, Yangsan, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research Institute, Pusan National University Hospital, Yangsan, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program of Genomic Data Sciences, Pusan National University, Yangsan, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="Y">Obesity</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000273" MajorTopicYN="N">Adipose Tissue</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056724" MajorTopicYN="N">Immunity, Humoral</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE2</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">adipose tissue</Keyword><Keyword MajorTopicYN="N">immunity</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">obesity</Keyword><Keyword MajorTopicYN="N">post COVID-19 condition</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>27</Day><Hour>9</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>27</Day><Hour>9</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>27</Day><Hour>4</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39188722</ArticleId><ArticleId IdType="pmc">PMC11345197</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2024.1433531</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Drucker DJ. Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning. Cell Metab. (2021) 33:479&#x2013;98. doi:&#xa0;10.1016/j.cmet.2021.01.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.01.016</ArticleId><ArticleId IdType="pmc">PMC7825982</ArticleId><ArticleId IdType="pubmed">33529600</ArticleId></ArticleIdList></Reference><Reference><Citation>Kambhampati AK, O&#x2019;Halloran AC, Whitaker M, Magill SS, Chea N, Chai SJ, et al. . COVID-19&#x2013;associated hospitalizations among health care personnel&#x2014;COVID-NET, 13 states, March 1&#x2013;May 31, 2020. Morbidity Mortality Weekly Rep. (2020) 69:1576. doi:&#xa0;10.15585/mmwr.mm6943e3</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6943e3</ArticleId><ArticleId IdType="pmc">PMC7659917</ArticleId><ArticleId IdType="pubmed">33119554</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan DH, Ravussin E, Heymsfield S. COVID 19 and the patient with obesity&#x2013;the editors speak out. Obes (Silver Spring Md). (2020) 28:847. doi:&#xa0;10.1002/oby.22808</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/oby.22808</ArticleId><ArticleId IdType="pmc">PMC7228389</ArticleId><ArticleId IdType="pubmed">32237212</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Ma Z, Lei Y. A meta-analysis of the association between obesity and COVID-19. Epidemiol Infection. (2021) 149:e11. doi:&#xa0;10.1017/S0950268820003027</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268820003027</ArticleId><ArticleId IdType="pmc">PMC7844214</ArticleId><ArticleId IdType="pubmed">33349290</ArticleId></ArticleIdList></Reference><Reference><Citation>Seidu S, Gillies C, Zaccardi F, Kunutsor SK, Hartmann-Boyce J, Yates T, et al. . The impact of obesity on severe disease and mortality in people with SARS-CoV-2: a systematic review and meta-analysis. Endocrinol Diabetes Metab. (2021) 4:e00176. doi:&#xa0;10.1002/edm2.176</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/edm2.176</ArticleId><ArticleId IdType="pmc">PMC7460942</ArticleId><ArticleId IdType="pubmed">32904932</ArticleId></ArticleIdList></Reference><Reference><Citation>Foldi M, Farkas N, Kiss S, Dembrovszky F, Szakacs Z, Balasko M, et al. . Visceral adiposity elevates the risk of critical condition in COVID-19: A systematic review and meta-analysis. Obes (Silver Spring). (2021) 29:521&#x2013;8. doi:&#xa0;10.1002/oby.23096</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/oby.23096</ArticleId><ArticleId IdType="pmc">PMC7753720</ArticleId><ArticleId IdType="pubmed">33263191</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunnell KM, Thaweethai T, Buckless C, Shinnick DJ, Torriani M, Foulkes AS, et al. . Body composition predictors of outcome in patients with COVID-19. Int J Obes (Lond). (2021) 45:2238&#x2013;43. doi:&#xa0;10.1038/s41366-021-00907-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41366-021-00907-1</ArticleId><ArticleId IdType="pmc">PMC8267764</ArticleId><ArticleId IdType="pubmed">34244597</ArticleId></ArticleIdList></Reference><Reference><Citation>Surov A, Thormann M, Kardas H, Hinnerichs M, Omari J, Cingoz E, et al. . Visceral to subcutaneous fat ratio predicts short-term mortality in patients with Covid 19. A Multicenter Study Br J Radiol. (2023) 96:20220869. doi:&#xa0;10.1259/bjr.20220869</Citation><ArticleIdList><ArticleId IdType="doi">10.1259/bjr.20220869</ArticleId><ArticleId IdType="pmc">PMC10078869</ArticleId><ArticleId IdType="pubmed">36744766</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. . Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. (2022) 28:1706&#x2013;14. doi:&#xa0;10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>de Barros GAM, da Silva DIC, Barbosa MLA, Soares RA, Alves RL, Miranda CL, et al. . Chronic pain after hospital discharge on patients hospitalized for COVID-19: an observational study. Braz J Anesthesiol (English Ed). (2023) 74:744457. doi:&#xa0;10.1016/j.bjane.2023.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjane.2023.08.001</ArticleId><ArticleId IdType="pmc">PMC11281913</ArticleId><ArticleId IdType="pubmed">37562649</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemos MM, Cavalini GR, Pugliese Henrique CR, Perli VAS, de Moraes Marchiori G, Marchiori L, et al. . Body composition and cardiorespiratory fitness in overweight or obese people post COVID-19: A comparative study. Front Physiol. (2022) 13:949351. doi:&#xa0;10.3389/fphys.2022.949351</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2022.949351</ArticleId><ArticleId IdType="pmc">PMC9532828</ArticleId><ArticleId IdType="pubmed">36213222</ArticleId></ArticleIdList></Reference><Reference><Citation>Bildirici Y, Metintas S, Ucan A, Ak G, Metintas M, Guvenc S. post-COVID-19 condition in a cohort of hospitalized COVID-19 patients. Eur Rev Med Pharmacol Sci. (2023) 27. doi:&#xa0;10.26355/eurrev_202309_33589</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202309_33589</ArticleId><ArticleId IdType="pubmed">37750657</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, Riley S, Darzi A, Cooke G, et al. . Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. (2022) 13:1957. doi:&#xa0;10.1038/s41467-022-29521-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan PM, Caplice NM. Is adipose tissue a reservoir for viral spread, immune activation, and cytokine amplification in coronavirus disease 2019? Obesity. (2020) 28:1191&#x2013;4. doi:&#xa0;10.1002/oby.22843</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/oby.22843</ArticleId><ArticleId IdType="pmc">PMC7264526</ArticleId><ArticleId IdType="pubmed">32314868</ArticleId></ArticleIdList></Reference><Reference><Citation>Damouche A, Lazure T, Avettand-F&#xe8;no&#xeb;l V, Huot N, Dejucq-Rainsford N, Satie A-P, et al. . Adipose tissue is a neglected viral reservoir and an inflammatory site during chronic HIV and SIV infection. PloS Pathog. (2015) 11:e1005153. doi:&#xa0;10.1371/journal.ppat.1005153</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005153</ArticleId><ArticleId IdType="pmc">PMC4581628</ArticleId><ArticleId IdType="pubmed">26402858</ArticleId></ArticleIdList></Reference><Reference><Citation>Couturier J, Agarwal N, Nehete PN, Baze WB, Barry MA, Jagannadha Sastry K, et al. . Infectious SIV resides in adipose tissue and induces metabolic defects in chronically infected rhesus macaques. Retrovirology. (2016) 13:1&#x2013;14. doi:&#xa0;10.1186/s12977-016-0260-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12977-016-0260-2</ArticleId><ArticleId IdType="pmc">PMC4847269</ArticleId><ArticleId IdType="pubmed">27117277</ArticleId></ArticleIdList></Reference><Reference><Citation>Oseghale O, Liong S, Coward-Smith M, To EE, Erlich JR, Luong R, et al. . Influenza A virus elicits peri-vascular adipose tissue inflammation and vascular dysfunction of the aorta in pregnant mice. PloS Pathog. (2022) 18:e1010703. doi:&#xa0;10.1371/journal.ppat.1010703</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010703</ArticleId><ArticleId IdType="pmc">PMC9385053</ArticleId><ArticleId IdType="pubmed">35930608</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, Ramelli SC, Grazioli A, Chung J-Y, Singh M, Yinda CK, et al. . SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. (2022) 612:758&#x2013;63. doi:&#xa0;10.1038/s41586-022-05542-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanley B, Naresh KN, Roufosse C, Nicholson AG, Weir J, Cooke GS, et al. . Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study. Lancet Microbe. (2020) 1:e245&#x2013;e53. doi:&#xa0;10.1016/S2666-5247(20)30115-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(20)30115-4</ArticleId><ArticleId IdType="pmc">PMC7440861</ArticleId><ArticleId IdType="pubmed">32844161</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao X-H, Luo T, Shi Y, He Z-C, Tang R, Zhang P-P, et al. . A cohort autopsy study defines COVID-19 systemic pathogenesis. Cell Res. (2021) 31:836&#x2013;46. doi:&#xa0;10.1038/s41422-021-00523-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-021-00523-8</ArticleId><ArticleId IdType="pmc">PMC8208380</ArticleId><ArticleId IdType="pubmed">34135479</ArticleId></ArticleIdList></Reference><Reference><Citation>Basolo A, Poma A, Bonuccelli D, Proietti A, Macerola E, Ugolini C, et al. . Adipose tissue in COVID-19: detection of SARS-CoV-2 in adipocytes and activation of the interferon-alpha response. J Endocrinol Invest. (2022) 45:1021&#x2013;9. doi:&#xa0;10.1007/s40618-022-01742-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-022-01742-5</ArticleId><ArticleId IdType="pmc">PMC8852916</ArticleId><ArticleId IdType="pubmed">35169984</ArticleId></ArticleIdList></Reference><Reference><Citation>Hany M, Zidan A, Gaballa M, Ibrahim M, Agayby ASS, Abouelnasr AA, et al. . Lingering SARS-coV-2 in gastric and gallbladder tissues of patients with previous COVID-19 infection undergoing bariatric surgery. Obes Surg. (2023) 33:139&#x2013;48. doi:&#xa0;10.1007/s11695-022-06338-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11695-022-06338-9</ArticleId><ArticleId IdType="pmc">PMC9628579</ArticleId><ArticleId IdType="pubmed">36316598</ArticleId></ArticleIdList></Reference><Reference><Citation>Zickler M, Stanelle-Bertram S, Ehret S, Heinrich F, Lange P, Schaumburg B, et al. . Replication of SARS-CoV-2 in adipose tissue determines organ and systemic lipid metabolism in hamsters and humans. Cell Metab. (2022) 34:1&#x2013;2. doi:&#xa0;10.1016/j.cmet.2021.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.12.002</ArticleId><ArticleId IdType="pmc">PMC8663969</ArticleId><ArticleId IdType="pubmed">34895500</ArticleId></ArticleIdList></Reference><Reference><Citation>Saccon TD, Mousovich-Neto F, Ludwig RG, Carregari VC, dos Anjos Souza AB, Dos Passos ASC, et al. . SARS-CoV-2 infects adipose tissue in a fat depot-and viral lineage-dependent manner. Nat Commun. (2022) 13:5722. doi:&#xa0;10.1038/s41467-022-33218-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33218-8</ArticleId><ArticleId IdType="pmc">PMC9521555</ArticleId><ArticleId IdType="pubmed">36175400</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Col&#xf3;n GJ, Ratnasiri K, Chen H, Jiang S, Zanley E, Rustagi A, et al. . SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages. Sci Trans Med. (2022) 14:eabm9151. doi:&#xa0;10.1126/scitranslmed.abm9151</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abm9151</ArticleId><ArticleId IdType="pmc">PMC9529056</ArticleId><ArticleId IdType="pubmed">36137009</ArticleId></ArticleIdList></Reference><Reference><Citation>Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, Bergmann O, et al. . Dynamics of fat cell turnover in humans. Nature. (2008) 453:783&#x2013;7. doi:&#xa0;10.1038/nature06902</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06902</ArticleId><ArticleId IdType="pubmed">18454136</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin DE. Why does viral RNA sometimes persist after recovery from acute infections? PloS Biol. (2022) 20:e3001687. doi:&#xa0;10.1371/journal.pbio.3001687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3001687</ArticleId><ArticleId IdType="pmc">PMC9191737</ArticleId><ArticleId IdType="pubmed">35648781</ArticleId></ArticleIdList></Reference><Reference><Citation>Thoms M, Buschauer R, Ameismeier M, Koepke L, Denk T, Hirschenberger M, et al. . Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2. Science. (2020) 369:1249&#x2013;55. doi:&#xa0;10.1126/science.abc8665</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc8665</ArticleId><ArticleId IdType="pmc">PMC7402621</ArticleId><ArticleId IdType="pubmed">32680882</ArticleId></ArticleIdList></Reference><Reference><Citation>Seitz T, Setz C, Rauch P, Schubert U, Hellerbrand C. Lipid accumulation in host cells promotes SARS-CoV-2 replication. Viruses. (2023) 15:1026. doi:&#xa0;10.3390/v15041026</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15041026</ArticleId><ArticleId IdType="pmc">PMC10142250</ArticleId><ArticleId IdType="pubmed">37113005</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenz M, Arts IC, Peeters RL, de Kok TM, Ertaylan G. Adipose tissue in health and disease through the lens of its building blocks. Sci Rep. (2020) 10:10433. doi:&#xa0;10.1038/s41598-020-67177-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-67177-1</ArticleId><ArticleId IdType="pmc">PMC7319996</ArticleId><ArticleId IdType="pubmed">32591560</ArticleId></ArticleIdList></Reference><Reference><Citation>Steenblock C, Bechmann N, Beuschlein F, Wolfrum C, Bornstein SR. Do adipocytes serve as a reservoir for severe acute respiratory syndrome coronavirus-2? J Endocrinol. (2023) 258. doi:&#xa0;10.1530/JOE-23-0027</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/JOE-23-0027</ArticleId><ArticleId IdType="pubmed">37227170</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiterer M, Rajan M, G&#xf3;mez-Banoy N, Lau JD, Gomez-Escobar LG, Ma L, et al. . Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2. Cell Metab. (2021) 33:2174&#x2013;88. doi:&#xa0;10.1016/j.cmet.2021.09.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.09.009</ArticleId><ArticleId IdType="pmc">PMC8443335</ArticleId><ArticleId IdType="pubmed">34599884</ArticleId></ArticleIdList></Reference><Reference><Citation>Suganami T, Nishida J, Ogawa Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor &#x3b1;. Arteriosclerosis Thrombosis Vasc Biol. (2005) 25:2062&#x2013;8. doi:&#xa0;10.1161/01.ATV.0000183883.72263.13</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.ATV.0000183883.72263.13</ArticleId><ArticleId IdType="pubmed">16123319</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott T, Owens MD. Thrombocytes respond to lipopolysaccharide through Toll-like receptor-4, and MAP kinase and NF-&#x3ba;B pathways leading to expression of interleukin-6 and cyclooxygenase-2 with production of prostaglandin E2. Mol Immunol. (2008) 45:1001&#x2013;8. doi:&#xa0;10.1016/j.molimm.2007.07.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2007.07.035</ArticleId><ArticleId IdType="pubmed">17825413</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamei N, Tobe K, Suzuki R, Ohsugi M, Watanabe T, Kubota N, et al. . Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem. (2006) 281:26602&#x2013;14. doi:&#xa0;10.1074/jbc.M601284200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M601284200</ArticleId><ArticleId IdType="pubmed">16809344</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Wang Z. Bench-to-bedside: Innovation of small molecule anti-SARS-CoV-2 drugs in China. Eur J Medicinal Chem. (2023), 115503. doi:&#xa0;10.1016/j.ejmech.2023.115503</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2023.115503</ArticleId><ArticleId IdType="pmc">PMC10193775</ArticleId><ArticleId IdType="pubmed">37229831</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M-Y, Li L, Zhang Y, Wang X-S. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty. (2020) 9:23&#x2013;9. doi:&#xa0;10.1186/s40249-020-00662-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-020-00662-x</ArticleId><ArticleId IdType="pmc">PMC7186534</ArticleId><ArticleId IdType="pubmed">32345362</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler CG, Allon SJ, Nyquist SK, Mbano IM, Miao VN, Tzouanas CN, et al. . SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. (2020) 181:1016&#x2013;35. doi:&#xa0;10.1016/j.cell.2020.04.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.035</ArticleId><ArticleId IdType="pmc">PMC7252096</ArticleId><ArticleId IdType="pubmed">32413319</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel VB, Basu R, Oudit GY. ACE2/Ang 1-7 axis: a critical regulator of epicardial adipose tissue inflammation and cardiac dysfunction in obesity. Adipocyte. (2016) 5:306&#x2013;11. doi:&#xa0;10.1080/21623945.2015.1131881</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21623945.2015.1131881</ArticleId><ArticleId IdType="pmc">PMC5014009</ArticleId><ArticleId IdType="pubmed">27617176</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, et al. . A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus&#x2013;induced lung injury. Nat Med. (2005) 11:875&#x2013;9. doi:&#xa0;10.1038/nm1267</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1267</ArticleId><ArticleId IdType="pmc">PMC7095783</ArticleId><ArticleId IdType="pubmed">16007097</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C-L, Abiona O, et al. . Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. (2020) 367:1260&#x2013;3. doi:&#xa0;10.1126/science.abb2507</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb2507</ArticleId><ArticleId IdType="pmc">PMC7164637</ArticleId><ArticleId IdType="pubmed">32075877</ArticleId></ArticleIdList></Reference><Reference><Citation>Snouwaert JN, Jania LA, Nguyen T, Martinez DR, Sch&#xe4;fer A, Catanzaro NJ, et al. . Human ACE2 expression, a major tropism determinant for SARS-CoV-2, is regulated by upstream and intragenic elements. PloS Pathog. (2023) 19:e1011168. doi:&#xa0;10.1371/journal.ppat.1011168</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1011168</ArticleId><ArticleId IdType="pmc">PMC9987828</ArticleId><ArticleId IdType="pubmed">36812267</ArticleId></ArticleIdList></Reference><Reference><Citation>Higuchi Y, Suzuki T, Arimori T, Ikemura N, Mihara E, Kirita Y, et al. . Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2. Nat Commun. (2021) 12:3802. doi:&#xa0;10.1038/s41467-021-24013-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24013-y</ArticleId><ArticleId IdType="pmc">PMC8217473</ArticleId><ArticleId IdType="pubmed">34155214</ArticleId></ArticleIdList></Reference><Reference><Citation>Song R, Chen X, Li B, Zhang H, Guo X, Liu Z, et al. . Nasal spray of an IgM-like ACE2 fusion protein HH-120 accelerates SARS-CoV-2 clearance: A single-center propensity score-matched cohort study. J Med Virol. (2023) 95:e28805. doi:&#xa0;10.1002/jmv.28805</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28805</ArticleId><ArticleId IdType="pubmed">37227062</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Zorita S, Milton-Laskibar I, Garcia-Arellano L, Gonzalez M, Portillo MP. An overview of adipose tissue ACE2 modulation by diet and obesity. Potential implications in COVID-19 infection and severity. Int J Mol Sci. (2021) 22:7975. doi:&#xa0;10.3390/ijms22157975</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22157975</ArticleId><ArticleId IdType="pmc">PMC8347022</ArticleId><ArticleId IdType="pubmed">34360741</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Benna S. Association of high level gene expression of ACE2 in adipose tissue with mortality of COVID-19 infection in obese patients. Obes Med. (2020) 19:100283. doi:&#xa0;10.1016/j.obmed.2020.100283</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.obmed.2020.100283</ArticleId><ArticleId IdType="pmc">PMC7368415</ArticleId><ArticleId IdType="pubmed">32835126</ArticleId></ArticleIdList></Reference><Reference><Citation>Favre G, Legueult K, Pradier C, Raffaelli C, Ichai C, Iannelli A, et al. . Visceral fat is associated to the severity of COVID-19. Metabolism. (2021) 115:154440. doi:&#xa0;10.1016/j.metabol.2020.154440</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2020.154440</ArticleId><ArticleId IdType="pmc">PMC7685947</ArticleId><ArticleId IdType="pubmed">33246009</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M. ACE2 and COVID-19 susceptibility and severity. Aging Dis. (2022) 13:360. doi:&#xa0;10.14336/AD.2021.0805</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2021.0805</ArticleId><ArticleId IdType="pmc">PMC8947832</ArticleId><ArticleId IdType="pubmed">35371596</ArticleId></ArticleIdList></Reference><Reference><Citation>Gheware A, Ray A, Rana D, Bajpai P, Nambirajan A, Arulselvi S, et al. . ACE2 protein expression in lung tissues of severe COVID-19 infection. Sci Rep. (2022) 12:4058. doi:&#xa0;10.1038/s41598-022-07918-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-07918-6</ArticleId><ArticleId IdType="pmc">PMC8902283</ArticleId><ArticleId IdType="pubmed">35260724</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann DM, Whettlock EM, Liu S, Arachchillage DJ, Boyton RJ. The immunology of long COVID. Nat Rev Immunol. (2023) 23:618&#x2013;34. doi:&#xa0;10.1038/s41577-023-00904-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-023-00904-7</ArticleId><ArticleId IdType="pubmed">37433988</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, Leavy OC, Richardson M, Elneima O, McAuley HJ, Shikotra A, et al. . Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med. (2022) 10:761&#x2013;75. doi:&#xa0;10.1016/S2213-2600(22)00127-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Unamuno X, G&#xf3;mez-Ambrosi J, Rodr&#xed;guez A, Becerril S, Fr&#xfc;hbeck G, Catal&#xe1;n V. Adipokine dysregulation and adipose tissue inflammation in human obesity. Eur J Clin Invest. (2018) 48:e12997. doi:&#xa0;10.1111/eci.12997</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.12997</ArticleId><ArticleId IdType="pubmed">29995306</ArticleId></ArticleIdList></Reference><Reference><Citation>Nigro E, D&#x2019;Agnano V, Quarcio G, Mariniello DF, Bianco A, Daniele A, et al. . Exploring the network between adipocytokines and inflammatory response in SARS-CoV-2 infection: a scoping review. Nutrients. (2023) 15:3806. doi:&#xa0;10.3390/nu15173806</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15173806</ArticleId><ArticleId IdType="pmc">PMC10490077</ArticleId><ArticleId IdType="pubmed">37686837</ArticleId></ArticleIdList></Reference><Reference><Citation>Bovill EG, Bild DE, Heiss G, Kuller LH, Lee MH, Rock R, et al. . White blood cell counts in persons aged 65 years or more from the Cardiovascular Health Study: correlations with baseline clinical and demographic characteristics. Am J Epidemiol. (1996) 143:1107&#x2013;15. doi:&#xa0;10.1093/oxfordjournals.aje.a008687</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a008687</ArticleId><ArticleId IdType="pubmed">8633599</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweetnam PM, Thomas HF, Yarnell JW, Baker IA, Elwood PC. Total and differential leukocyte counts as predictors of ischemic heart disease: the Caerphilly and Speedwell studies. Am J Epidemiol. (1997) 145:416&#x2013;21. doi:&#xa0;10.1093/oxfordjournals.aje.a009123</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a009123</ArticleId><ArticleId IdType="pubmed">9048515</ArticleId></ArticleIdList></Reference><Reference><Citation>Rexrode KM, Pradhan A, Manson JE, Buring JE, Ridker PM. Relationship of total and abdominal adiposity with CRP and IL-6 in women. Ann Epidemiol. (2003) 13:674&#x2013;82. doi:&#xa0;10.1016/S1047-2797(03)00053-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1047-2797(03)00053-X</ArticleId><ArticleId IdType="pubmed">14599731</ArticleId></ArticleIdList></Reference><Reference><Citation>Trujillo ME, Sullivan S, Harten I, Schneider SH, Greenberg AS, Fried SK. Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production. Vitro J Clin Endocrinol Metab. (2004) 89:5577&#x2013;82. doi:&#xa0;10.1210/jc.2004-0603</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2004-0603</ArticleId><ArticleId IdType="pubmed">15531514</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol Rev. (1998) 78:783&#x2013;809. doi:&#xa0;10.1152/physrev.1998.78.3.783</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.1998.78.3.783</ArticleId><ArticleId IdType="pubmed">9674695</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelesidis T, Kelesidis I, Chou S, Mantzoros CS. Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Internal Med. (2010) 152:93&#x2013;100. doi:&#xa0;10.7326/0003-4819-152-2-201001190-00008</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-152-2-201001190-00008</ArticleId><ArticleId IdType="pmc">PMC2829242</ArticleId><ArticleId IdType="pubmed">20083828</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellmeyer A, Martino JM, Chandel NS, Scott Budinger G, Dean DA, Mutlu G. Leptin resistance protects mice from hyperoxia-induced acute lung injury. Am J Respir Crit Care Med. (2007) 175:587&#x2013;94. doi:&#xa0;10.1164/rccm.200603-312OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200603-312OC</ArticleId><ArticleId IdType="pmc">PMC1899284</ArticleId><ArticleId IdType="pubmed">17185651</ArticleId></ArticleIdList></Reference><Reference><Citation>Assad NA, Sood A. Leptin, adiponectin and pulmonary diseases. Biochimie. (2012) 94:2180&#x2013;9. doi:&#xa0;10.1016/j.biochi.2012.03.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2012.03.006</ArticleId><ArticleId IdType="pmc">PMC3399062</ArticleId><ArticleId IdType="pubmed">22445899</ArticleId></ArticleIdList></Reference><Reference><Citation>Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature. (1998) 394:897&#x2013;901. doi:&#xa0;10.1038/29795</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/29795</ArticleId><ArticleId IdType="pubmed">9732873</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltodano-Calle MJ, Polo-Vasquez JS, Romani-Pozo A, Gutarra-Saldana D, Guija-Poma E. Leptin as a potential prognostic marker of the severity of COVID-19 infection in obese patients. Nutr Metab Cardiovasc Dis. (2022) 32:743&#x2013;4. doi:&#xa0;10.1016/j.numecd.2021.12.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.numecd.2021.12.003</ArticleId><ArticleId IdType="pmc">PMC8660140</ArticleId><ArticleId IdType="pubmed">35109999</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Xu Y, Zhang X, Wang S, Peng Z, Guo J, et al. . Leptin correlates with monocytes activation and severe condition in COVID-19 patients. J Leukoc Biol. (2021) 110:9&#x2013;20. doi:&#xa0;10.1002/JLB.5HI1020-704R</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.5HI1020-704R</ArticleId><ArticleId IdType="pmc">PMC10016867</ArticleId><ArticleId IdType="pubmed">33404078</ArticleId></ArticleIdList></Reference><Reference><Citation>Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodr&#xed;guez L. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. (2020) 54:62&#x2013;75. doi:&#xa0;10.1016/j.cytogfr.2020.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2020.06.001</ArticleId><ArticleId IdType="pmc">PMC7265853</ArticleId><ArticleId IdType="pubmed">32513566</ArticleId></ArticleIdList></Reference><Reference><Citation>Queiroz MAF, Neves P, Lima SS, Lopes J, Torres M, Vallinoto IMVC, et al. . Cytokine profiles associated with acute COVID-19 and long COVID-19 syndrome. Front Cell Infection Microbiol. (2022) 12:922422. doi:&#xa0;10.3389/fcimb.2022.922422</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.922422</ArticleId><ArticleId IdType="pmc">PMC9279918</ArticleId><ArticleId IdType="pubmed">35846757</ArticleId></ArticleIdList></Reference><Reference><Citation>Swain SL, Weinberg AD, English M, Huston G. IL-4 directs the development of Th2-like helper effectors. J Immunol (Baltimore Md: 1950). (1990) 145:3796&#x2013;806. doi:&#xa0;10.4049/jimmunol.145.11.3796</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.145.11.3796</ArticleId><ArticleId IdType="pubmed">2147202</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez JD, Li T, Ghannam H, Rau CM, Masuda MY, Madura JA, et al. . Linking adipose tissue eosinophils, IL-4, and leptin in human obesity and insulin resistance. JCI Insight. (2024) 9. doi:&#xa0;10.1172/jci.insight.170772</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.170772</ArticleId><ArticleId IdType="pmc">PMC10967463</ArticleId><ArticleId IdType="pubmed">38206766</ArticleId></ArticleIdList></Reference><Reference><Citation>Israelow B, Mao T, Klein J, Song E, Menasche B, Omer SB, et al. . Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2. Sci Immunol. (2021) 6:eabl4509. doi:&#xa0;10.1126/sciimmunol.abl4509</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abl4509</ArticleId><ArticleId IdType="pmc">PMC9047536</ArticleId><ArticleId IdType="pubmed">34623900</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z, Senussi Y, Alter G, Walt DR. Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae. Medrxiv. (2022). doi:&#xa0;10.1101/2022.06.14.22276401</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.06.14.22276401</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Neidich SD, Green WD, Rebeles J, Karlsson EA, Schultz-Cherry S, Noah TL, et al. . Increased risk of influenza among vaccinated adults who are obese. Int J Obes. (2017) 41:1324&#x2013;30. doi:&#xa0;10.1038/ijo.2017.131</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ijo.2017.131</ArticleId><ArticleId IdType="pmc">PMC5585026</ArticleId><ArticleId IdType="pubmed">28584297</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheridan PA, Paich HA, Handy J, Karlsson EA, Hudgens MG, Sammon AB, et al. . Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes. (2012) 36:1072&#x2013;7. doi:&#xa0;10.1038/ijo.2011.208</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ijo.2011.208</ArticleId><ArticleId IdType="pmc">PMC3270113</ArticleId><ArticleId IdType="pubmed">22024641</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi SS, Davis RP, Ma MM, Tam E, Cooper CL, Ramji A, et al. . Reduced immune responses to hepatitis B primary vaccination in obese individuals with nonalcoholic fatty liver disease (NAFLD). NPJ Vaccines. (2021) 6:9. doi:&#xa0;10.1038/s41541-020-00266-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-020-00266-4</ArticleId><ArticleId IdType="pmc">PMC7801497</ArticleId><ArticleId IdType="pubmed">33431890</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber DJ, Rutala WA, Samsa GP, Bradshaw SE, Lemon SM. Impaired immunogenicity of hepatitis B vaccine in obese persons. New Engl J Med. (1986) 314:1393. doi:&#xa0;10.1056/NEJM198605223142119</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM198605223142119</ArticleId><ArticleId IdType="pubmed">2939347</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou X, Jiang J, Lin B, Liu Q, Lin W, Chen G, et al. . Antibody responses to COVID-19 vaccination in people with obesity: A systematic review and meta-analysis. Influenza Other Respir Viruses. (2023) 17:e13078. doi:&#xa0;10.1111/irv.13078</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.13078</ArticleId><ArticleId IdType="pmc">PMC9835425</ArticleId><ArticleId IdType="pubmed">36535669</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Der Klaauw AA, Horner EC, Pereyra-Gerber P, Agrawal U, Foster WS, Spencer S, et al. . Accelerated waning of the humoral response to COVID-19 vaccines in obesity. Nat Med. (2023) 29:1146&#x2013;54. doi:&#xa0;10.1038/s41591-023-02343-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02343-2</ArticleId><ArticleId IdType="pmc">PMC10202802</ArticleId><ArticleId IdType="pubmed">37169862</ArticleId></ArticleIdList></Reference><Reference><Citation>Faizo AA, Qashqari FS, El-Kafrawy SA, Barasheed O, Almashjary MN, Alfelali M, et al. . A potential association between obesity and reduced effectiveness of COVID-19 vaccine-induced neutralizing humoral immunity. J Med Virol. (2023) 95:e28130. doi:&#xa0;10.1002/jmv.28130</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28130</ArticleId><ArticleId IdType="pmc">PMC9539352</ArticleId><ArticleId IdType="pubmed">36068377</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbiani DF, Gaebler C, Muecksch F, Lorenzi JC, Wang Z, Cho A, et al. . Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature. (2020) 584:437&#x2013;42. doi:&#xa0;10.1038/s41586-020-2456-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2456-9</ArticleId><ArticleId IdType="pmc">PMC7442695</ArticleId><ArticleId IdType="pubmed">32555388</ArticleId></ArticleIdList></Reference><Reference><Citation>Bettini E, Locci M. SARS-CoV-2 mRNA vaccines: immunological mechanism and beyond. Vaccines. (2021) 9:147. doi:&#xa0;10.3390/vaccines9020147</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9020147</ArticleId><ArticleId IdType="pmc">PMC7918810</ArticleId><ArticleId IdType="pubmed">33673048</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C, Zurbuchen Y, Taeschler P, Ballouz T, Menges D, Hasler S, et al. . Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun. (2022) 13:1&#x2013;12. doi:&#xa0;10.1038/s41467-021-27797-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27797-1</ArticleId><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Abell&#xe1;n J, Fern&#xe1;ndez M, Padilla S, Garc&#xed;a JA, Agull&#xf3; V, Lozano V, et al. . Immunologic phenotype of patients with long-COVID syndrome of 1-year duration. Front Immunol. (2022) 13:920627. doi:&#xa0;10.3389/fimmu.2022.920627</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.920627</ArticleId><ArticleId IdType="pmc">PMC9451924</ArticleId><ArticleId IdType="pubmed">36090973</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Greenhalgh T, Milne R, Delaney B. Are vaccines a potential treatment for long covid? Br Med J Publishing Group. (2022). doi:&#xa0;10.1136/bmj.o988</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o988</ArticleId><ArticleId IdType="pubmed">35584848</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bermingham C, Pouwels KB, Glickman M, Nafilyan V, Zaccardi F, et al. . Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. bmj. (2022) 377. doi:&#xa0;10.1136/bmj-2021-069676</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchida T, Hirose M, Inoue Y, Kunishima H, Otsubo T, Matsuda T. Relationship between changes in symptoms and antibody titers after a single vaccination in patients with Long COVID. J Med Virol. (2022) 94:3416&#x2013;20. doi:&#xa0;10.1002/jmv.27689</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27689</ArticleId><ArticleId IdType="pmc">PMC9088489</ArticleId><ArticleId IdType="pubmed">35238053</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Ding F, Bao W, Xue Y, Han L, Zhang X, et al. . Clinical features in coronavirus disease 2019 (COVID-19) patients with early clearance and prolonged shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA. Ann Trans Med. (2021) 9:665. doi:&#xa0;10.21037/atm</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm</ArticleId><ArticleId IdType="pmc">PMC8106067</ArticleId><ArticleId IdType="pubmed">33987363</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong W, Park Y-K, Kim B-O, Park SK, Shin J, Jang S-P, et al. . Use of combined treatment of 3rd-generation cephalosporin, azithromycin and antiviral agents on moderate SARs-CoV-2 patients in South Korea: A retrospective cohort study. PloS One. (2022) 17:e0267645. doi:&#xa0;10.1371/journal.pone.0267645</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0267645</ArticleId><ArticleId IdType="pmc">PMC9067652</ArticleId><ArticleId IdType="pubmed">35507600</ArticleId></ArticleIdList></Reference><Reference><Citation>Croft M, Swain SL. B cell response to fresh and effector T helper cells. Role of cognate TB interaction and the cytokines IL-2, IL-4, and IL-6. J Immunol (Baltimore Md: 1950). (1991) 146:4055&#x2013;64. doi:&#xa0;10.4049/jimmunol.146.12.4055</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.146.12.4055</ArticleId><ArticleId IdType="pubmed">1828258</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbas AK, Urioste S, Collins T, Boom W. Heterogeneity of helper/inducer T lymphocytes. IV. Stimulation of resting and activated B cells by Th1 and Th2 clones. J Immunol (Baltimore Md: 1950). (1990) 144:2031&#x2013;7. doi:&#xa0;10.4049/jimmunol.144.6.2031</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.144.6.2031</ArticleId><ArticleId IdType="pubmed">2138191</ArticleId></ArticleIdList></Reference><Reference><Citation>Boom WH, Liano D, Abbas AK. Heterogeneity of helper/inducer T lymphocytes. II. Effects of interleukin 4-and interleukin 2-producing T cell clones on resting B lymphocytes. J Exp Med. (1988) 167:1350&#x2013;63. doi:&#xa0;10.1084/jem.167.4.1350</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.167.4.1350</ArticleId><ArticleId IdType="pmc">PMC2188922</ArticleId><ArticleId IdType="pubmed">2965736</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MD, Nedjai B, Hurst T, Pennington DJ. Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta (BBA)-Molecular Cell Res. (2014) 1843:2563&#x2013;82. doi:&#xa0;10.1016/j.bbamcr.2014.05.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2014.05.014</ArticleId><ArticleId IdType="pubmed">24892271</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue-Xi Y, Fen-Xia L, Wu Y-S, Wu D, Jia-Yu T, Li M. Association of TGF-[beta] 1, IL-4 and IL-13 gene polymerphisms with asthma in a Chinese population. Asian Pacific J Allergy Immunol. (2011) 29:273.</Citation><ArticleIdList><ArticleId IdType="pubmed">22053598</ArticleId></ArticleIdList></Reference><Reference><Citation>Snapper C, Finkelman F, Paul W. Differential regulation of IgG1 and IgE synthesis by interleukin 4. J Exp Med. (1988) 167:183&#x2013;96. doi:&#xa0;10.1084/jem.167.1.183</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.167.1.183</ArticleId><ArticleId IdType="pmc">PMC2188810</ArticleId><ArticleId IdType="pubmed">3257252</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebman DA, Coffman RL. The effects of IL-4 and IL-5 on the IgA response by murine Peyer's patch B cell subpopulations. J Immunol. (1988) 141:2050&#x2013;6. doi:&#xa0;10.4049/jimmunol.141.6.2050</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.141.6.2050</ArticleId><ArticleId IdType="pubmed">3262648</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray PD, McKenzie DT, Swain SL, Kagnoff MF. Interleukin 5 and interleukin 4 produced by Peyer's patch T cells selectively enhance immunoglobulin A expression. J Immunol. (1987) 139:2669&#x2013;74. doi:&#xa0;10.4049/jimmunol.139.8.2669</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.139.8.2669</ArticleId><ArticleId IdType="pubmed">3498768</ArticleId></ArticleIdList></Reference><Reference><Citation>Matarese G. Leptin and the immune system: how nutritional status influences the immune response. Eur Cytokine Network. (2000) 11:7&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">10705294</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka S-i, Isoda F, Yamakawa T, Ishihara M, Sekihara H. T lymphopenia in genetically obese rats. Clin Immunol Immunopathol. (1998) 86:219&#x2013;25. doi:&#xa0;10.1006/clin.1997.4467</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/clin.1997.4467</ArticleId><ArticleId IdType="pubmed">9473385</ArticleId></ArticleIdList></Reference><Reference><Citation>Loffreda S, Yang S, Lin H, Karp C, Brengman ML, Wang D, et al. . Leptin regulates proinflammatory immune responses. FASEB J. (1998) 12:57&#x2013;65. doi:&#xa0;10.1096/fsb2fasebj.12.1.57</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fsb2fasebj.12.1.57</ArticleId><ArticleId IdType="pubmed">9438411</ArticleId></ArticleIdList></Reference><Reference><Citation>Moshyedi AK, Josephs MD, Abdalla EK, MacKay SL, Edwards CK, III, Copeland EM, III, et al. . Increased leptin expression in mice with bacterial peritonitis is partially regulated by tumor necrosis factor alpha. Infection Immun. (1998) 66:1800&#x2013;2. doi:&#xa0;10.1128/IAI.66.4.1800-1802.1998</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.66.4.1800-1802.1998</ArticleId><ArticleId IdType="pmc">PMC108125</ArticleId><ArticleId IdType="pubmed">9529118</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandra R, Kutty K. Immunocompetence in obesity. Acta P&#xe6;diatrica. (1980) 69:25&#x2013;30. doi:&#xa0;10.1111/j.1651-2227.1980.tb07024.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1651-2227.1980.tb07024.x</ArticleId><ArticleId IdType="pubmed">7368908</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieman DC, Henson DA, Nehlsen-Cannarella SL, Ekkens M, Utter AC, Butterworth DE, et al. . Influence of obesity on immune function. J Am Dietetic Assoc. (1999) 99:294&#x2013;9. doi:&#xa0;10.1016/S0002-8223(99)00077-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-8223(99)00077-2</ArticleId><ArticleId IdType="pubmed">10076580</ArticleId></ArticleIdList></Reference><Reference><Citation>La Gruta NL, Turner SJ. T cell mediated immunity to influenza: mechanisms of viral control. Trends Immunol. (2014) 35:396&#x2013;402. doi:&#xa0;10.1016/j.it.2014.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2014.06.004</ArticleId><ArticleId IdType="pubmed">25043801</ArticleId></ArticleIdList></Reference><Reference><Citation>Delhanty PJ, Huisman M, Baldeon-Rojas LY, van den Berge I, Grefhorst A, Abribat T, et al. . Des-acyl ghrelin analogs prevent high-fat-diet-induced dysregulation of glucose homeostasis. FASEB J. (2013) 27:1690&#x2013;700.</Citation><ArticleIdList><ArticleId IdType="pubmed">23299855</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia C, Rao X, Zhong J. Role of T lymphocytes in type 2 diabetes and diabetes-associated inflammation. J Diabetes Res. (2017) 2017:6494795. doi:&#xa0;10.1155/2017/6494795</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/6494795</ArticleId><ArticleId IdType="pmc">PMC5307004</ArticleId><ArticleId IdType="pubmed">28251163</ArticleId></ArticleIdList></Reference><Reference><Citation>Porsche CE, Delproposto JB, Geletka L, O&#x2019;Rourke R, Lumeng CN. Obesity results in adipose tissue T cell exhaustion. JCI Insight. (2021) 6. doi:&#xa0;10.1172/jci.insight.139793</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.139793</ArticleId><ArticleId IdType="pmc">PMC8119198</ArticleId><ArticleId IdType="pubmed">33724954</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Willscher E, Paschold L, Gottschick C, Klee B, Henkes S-S, et al. . The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med. (2022) 3. doi:&#xa0;10.1016/j.xcrm.2022.100663</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Tang L, Ma Y, Li Y, Zhang D, Li Q, et al. . Immunological profiling of COVID-19 patients with pulmonary sequelae. MBio. (2021) 12:10. doi:&#xa0;10.1128/mBio.01599-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01599-21</ArticleId><ArticleId IdType="pmc">PMC8546863</ArticleId><ArticleId IdType="pubmed">34488453</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. . Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. (2022) 23:210&#x2013;6. doi:&#xa0;10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Kratzer B, Trapin D, Ettel P, K&#xf6;rm&#xf6;czi U, Rottal A, Tuppy F, et al. . Immunological imprint of COVID-19 on human peripheral blood leukocyte populations. Allergy. (2021) 76:751&#x2013;65. doi:&#xa0;10.1111/all.14647</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14647</ArticleId><ArticleId IdType="pmc">PMC7984452</ArticleId><ArticleId IdType="pubmed">33128792</ArticleId></ArticleIdList></Reference><Reference><Citation>Ausiello CM, Urbani F, la Sala A, Funaro A, Malavasi F. CD38 ligation induces discrete cytokine mRNA expression in human cultured lymphocytes. Eur J Immunol. (1995) 25:1477&#x2013;80. doi:&#xa0;10.1002/eji.1830250554</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.1830250554</ArticleId><ArticleId IdType="pubmed">7774653</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiech M, Chroscicki P, Swatler J, Stepnik D, De Biasi S, Hampel M, et al. . Remodeling of T cell dynamics during long COVID is dependent on severity of SARS-CoV-2 infection. Front Immunol. (2022) 13:886431. doi:&#xa0;10.3389/fimmu.2022.886431</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.886431</ArticleId><ArticleId IdType="pmc">PMC9226563</ArticleId><ArticleId IdType="pubmed">35757700</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J, Wood J, Jaycox JR, Dhodapkar RM, Lu P, Gehlhausen JR, et al. . Distinguishing features of Long COVID identified through immune profiling. Nature. (2023) 623:139&#x2013;48. doi:&#xa0;10.1038/s41586-023-06651-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06651-y</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Jubel JM, Barbati ZR, Burger C, Schildberg FA. The role of PD-1 in acute and chronic infection. Front Immunol. (2020) 11:524474. doi:&#xa0;10.3389/fimmu.2020.00487</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00487</ArticleId><ArticleId IdType="pmc">PMC7105608</ArticleId><ArticleId IdType="pubmed">32265932</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. jama. (2020) 323:1239&#x2013;42. doi:&#xa0;10.1001/jama.2020.2648</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Popkin BM, Du S, Green WD, Beck MA, Algaith T, Herbst CH, et al. . Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships. Obes Rev. (2020) 21:e13128. doi:&#xa0;10.1111/obr.13128</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/obr.13128</ArticleId><ArticleId IdType="pmc">PMC7461480</ArticleId><ArticleId IdType="pubmed">32845580</ArticleId></ArticleIdList></Reference><Reference><Citation>Moser J, Emous M, Heeringa P, Rodenhuis-Zybert IA. Mechanisms and pathophysiology of SARS-CoV-2 infection of the adipose tissue. Trends Endocrinol Metab. (2023). doi:&#xa0;10.1016/j.tem.2023.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2023.08.010</ArticleId><ArticleId IdType="pubmed">37673763</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes. (2007) 56:1010&#x2013;3. doi:&#xa0;10.2337/db06-1656</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db06-1656</ArticleId><ArticleId IdType="pubmed">17287468</ArticleId></ArticleIdList></Reference><Reference><Citation>Barchetta I, Cimini F, Ciccarelli G, Baroni M, Cavallo M. Sick fat: the good and the bad of old and new circulating markers of adipose tissue inflammation. J Endocrinol Invest. (2019) 42:1257&#x2013;72. doi:&#xa0;10.1007/s40618-019-01052-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-019-01052-3</ArticleId><ArticleId IdType="pubmed">31073969</ArticleId></ArticleIdList></Reference><Reference><Citation>Graziano E, Peghin M, De Martino M, De Carlo C, Da Porto A, Bulfone L, et al. . The impact of body composition on mortality of COVID-19 hospitalized patients: A prospective study on abdominal fat, obesity paradox and sarcopenia. Clin Nutr ESPEN. (2022) 51:437&#x2013;44. doi:&#xa0;10.1016/j.clnesp.2022.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnesp.2022.07.003</ArticleId><ArticleId IdType="pmc">PMC9295328</ArticleId><ArticleId IdType="pubmed">36184240</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvehus M, Bur&#xe9;n J, Sj&#xf6;str&#xf6;m M, Goedecke J, Olsson T. The human visceral fat depot has a unique inflammatory profile. Obesity. (2010) 18:879&#x2013;83. doi:&#xa0;10.1038/oby.2010.22</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/oby.2010.22</ArticleId><ArticleId IdType="pubmed">20186138</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Jiang Q, Xia X, Liu K, Yu Z, Tao W, et al. . Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation. Aging Cell. (2020) 19:e13168. doi:&#xa0;10.1111/acel.13168</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.13168</ArticleId><ArticleId IdType="pmc">PMC7323071</ArticleId><ArticleId IdType="pubmed">32558150</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Choudhary MC, Regan J, Boucau J, Nathan A, Speidel T, et al. . SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency. Sci Trans Med. (2024) 16:eadk1599. doi:&#xa0;10.1126/scitranslmed.adk1599</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.adk1599</ArticleId><ArticleId IdType="pmc">PMC10982957</ArticleId><ArticleId IdType="pubmed">38266109</ArticleId></ArticleIdList></Reference><Reference><Citation>Eliakim A, Swindt C, Zaldivar F, Casali P, Cooper DM. Reduced tetanus antibody titers in overweight children. Autoimmunity. (2006) 39:137&#x2013;41. doi:&#xa0;10.1080/08916930600597326</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916930600597326</ArticleId><ArticleId IdType="pmc">PMC4623573</ArticleId><ArticleId IdType="pubmed">16698670</ArticleId></ArticleIdList></Reference><Reference><Citation>Esp&#xed;n E, Yang C, Shannon CP, Assadian S, He D, Tebbutt SJ. Cellular and molecular biomarkers of long COVID: a scoping review. EBioMedicine. (2023) 91. doi:&#xa0;10.1016/j.ebiom.2023.104552</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104552</ArticleId><ArticleId IdType="pmc">PMC10082390</ArticleId><ArticleId IdType="pubmed">37037165</ArticleId></ArticleIdList></Reference><Reference><Citation>Winn NC, Cottam MA, Wasserman DH, Hasty AH. Exercise and adipose tissue immunity: outrunning inflammation. Obesity. (2021) 29:790&#x2013;801. doi:&#xa0;10.1002/oby.23147</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/oby.23147</ArticleId><ArticleId IdType="pubmed">33899336</ArticleId></ArticleIdList></Reference><Reference><Citation>Florencio LL, Fern&#xe1;ndez-de-Las-Pe&#xf1;as C. Long COVID: systemic inflammation and obesity as therapeutic targets. Lancet Respir Med. (2022) 10:726&#x2013;7. doi:&#xa0;10.1016/S2213-2600(22)00159-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00159-X</ArticleId><ArticleId IdType="pmc">PMC9034853</ArticleId><ArticleId IdType="pubmed">35472305</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrea L, Vetrani C, Caprio M, Cataldi M, Ghoch ME, Elce A, et al. . From the ketogenic diet to the Mediterranean diet: the potential dietary therapy in patients with obesity after CoVID-19 infection (Post CoVID syndrome). Curr Obes Rep. (2022) 11:144&#x2013;65. doi:&#xa0;10.1007/s13679-022-00475-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13679-022-00475-z</ArticleId><ArticleId IdType="pmc">PMC9075143</ArticleId><ArticleId IdType="pubmed">35524067</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe M, Balena A, Masi D, Tozzi R, Risi R, Caputi A, et al. . Rapid weight loss, central obesity improvement and blood glucose reduction are associated with a stronger adaptive immune response following COVID-19 mRNA vaccine. Vaccines. (2022) 10:79. doi:&#xa0;10.3390/vaccines10010079</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10010079</ArticleId><ArticleId IdType="pmc">PMC8780354</ArticleId><ArticleId IdType="pubmed">35062740</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-Cordero L, G&#xe1;lvez I, HinChado MD, Ortega E. &#x3b2;2 adrenergic regulation of the phagocytic and microbicide capacity of macrophages from obese and lean mice: Effects of exercise. Nutrients. (2019) 11:2721. doi:&#xa0;10.3390/nu11112721</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11112721</ArticleId><ArticleId IdType="pmc">PMC6893822</ArticleId><ArticleId IdType="pubmed">31717554</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira AG, Araujo TG, Carvalho BM, Guadagnini D, Rocha GZ, Bagarolli RA, et al. . Acute exercise induces a phenotypic switch in adipose tissue macrophage polarization in diet-induced obese rats. Obesity. (2013) 21:2545&#x2013;56. doi:&#xa0;10.1002/oby.20402</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/oby.20402</ArticleId><ArticleId IdType="pubmed">23512570</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramante CT, Buse JB, Liebovitz DM, Nicklas JM, Puskarich MA, Cohen K, et al. . Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial. Lancet Infect Dis. (2023) 23:1119&#x2013;29. doi:&#xa0;10.1016/S1473-3099(23)00299-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00299-2</ArticleId><ArticleId IdType="pmc">PMC11259948</ArticleId><ArticleId IdType="pubmed">37302406</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams CG, Jureka AS, Silvas JA, Nicolini AM, Chvatal SA, Carlson-Stevermer J, et al. . Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication. Cell Rep. (2021) 36. doi:&#xa0;10.1016/j.celrep.2021.109479</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109479</ArticleId><ArticleId IdType="pmc">PMC8289695</ArticleId><ArticleId IdType="pubmed">34320401</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, Buxton M, Husain L. Management of post-acute covid-19 in primary care. bmj. (2020) 370. doi:&#xa0;10.1136/bmj.m3026</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. bmj. (2021) 372. doi:&#xa0;10.1136/bmj.n136</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>